The Galapagos share

The Galapagos share

Galapagos NV (ticker: GLPG) has been listed on Euronext Amsterdam and Brussels since 6 May 2005 and on the NASDAQ Global Select Market since 14 May 2015. Galapagos NV forms part of the Bel20 index (top 20 listed companies) on Euronext Brussels and the AEX Index (top 25 listed companies) on Euronext Amsterdam.

The Galapagos share in 2016

The Galapagos share in 2016 (line chart)The Galapagos share in 2016 (line chart)

In 2016, the average daily trading volume on Euronext was 259,885 shares and €13 million turnover. The daily trading volume on NASDAQ in 2016 was 91,397 ADSs and $5.0 million turnover.

Galapagos vs Next Biotech Index in 2016

Galapagos vs Next Biotech Index in 2016 (line chart)Galapagos vs Next Biotech Index in 2016 (line chart)

Galapagos vs Nasdaq Biotechnology Index

Galapagos vs Nasdaq Biotechnology 2016 (line chart)Galapagos vs Nasdaq Biotechnology 2016 (line chart)

Investor relations activities

We attracted additional sell-side analyst coverage by U.S. banks. Our IR team presented at a number of conferences in 2016 and did several of broker-organized and self-organized roadshows throughout the U.S. and Europe. We presented Full Year, Half Year and Q1 and Q3 2016 results and our R&D Update via webcasts.

The main topics of discussion with investors included the filgotinib DARWIN and FITZROY program results and progress on our plans to develop a triple combination therapy for cystic fibrosis patients.